Logo
Subscribe Now

All Posts by Date

PharmaShots Weekly Snapshots (April 26 – 30, 2021)

PharmaShots Weekly Snapshots (April 26 – 30, 2021)

Hikma' Kloxxado (naloxone hydrochloride) Receives the US FDA's Approval for the Treatment of Opioid Overdose

Hikma' Kloxxado (naloxone hydrochloride) Receives the US FDA's Approval for the Treatment of Opioid Overdose

12th Summit on Biosimilars & Innovator Biologics

12th Summit on Biosimilars & Innovator Biologics

Alphamab and Pfizer Initiate P-II Trial Evaluating KN046 + Inlyta (axitinib) as a 1L Treatment of Non-Small Cell Lung Cancer

Alphamab and Pfizer Initiate P-II Trial Evaluating KN046 + Inlyta (axitinib) as a 1L Treatment of Non-Small Cell Lung Cancer

Innovent Reports First Patient Dosing in P-II Trial of IBI302 for Neovascular Age-Related Macular Degeneration

Innovent Reports First Patient Dosing in P-II Trial of IBI302 for Neovascular Age-Related Macular Degeneration

Celltrion Reports Results of Regdanvimab (CT-P59) in Pre-Clinical Study Against the South African Variant (B.1.351)

Celltrion Reports Results of Regdanvimab (CT-P59) in Pre-Clinical Study Against the South African Variant (B.1.351)

Image

Stay Connected

We Have a Viewership of 1,00,000 + Views

Join the PharmaShot Family

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2021 PharmaShots - All Rights Reserved.